Results 151 to 160 of about 50,819 (268)

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

open access: yesArthritis Care &Research, Volume 78, Issue 9, Page 1123-1129, September 2026.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino   +9 more
wiley   +1 more source

Idiopathic Orbital Inflammation Masquerading as Relapse of Seronegative Juvenile Myasthenia Gravis: A Case Report

open access: yes
Journal of Paediatrics and Child Health, EarlyView.
Wenhao Duan   +4 more
wiley   +1 more source

MCH‐Guard: Multimodal machine learning framework for risk stratification of cerebral microhemorrhage risk in the Alzheimer's Disease Neuroimaging Initiative

open access: yesAlzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract INTRODUCTION Efficient cerebral microhemorrhage (MCH) monitoring is critical for anti‐amyloid therapy safety due to amyloid‐related imaging abnormalities with hemosiderin deposition (ARIA‐H) risk. We developed MCH‐Guard, a multimodal machine‐learning framework, to stratify MCH risk for Alzheimer's Disease Neuroimaging Initiaitive (ADNI ...
Alper Gel   +5 more
wiley   +1 more source

Current advances in 2025: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Nabiha H. Saifee   +24 more
wiley   +1 more source

Single‐Cell Level Characterization of B Cell Depletion and Repopulation Following Rituximab in Systemic Lupus Erythematosus

open access: yesArthritis &Rheumatology, Volume 78, Issue 9, Page 1907-1919, September 2026.
Objective Rituximab, a CD20+ B cell depletion therapy, is frequently used to treat systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopulation.
Haerin Jang   +9 more
wiley   +1 more source

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma

open access: yes
American Journal of Hematology, Volume 101, Issue 10, Page 2652-2653, October 2026.
Léa Ousset   +2 more
wiley   +1 more source

Associations of Weight and Glucose Levels With Myasthenia Gravis: A Two‐Step, Two‐Sample Mendelian Randomization and Retrospective Case‐Control Study

open access: yesBrain and Behavior, Volume 16, Issue 9, September 2026.
In a two‐step, two‐sample Mendelian randomization framework, genetically predicted higher weight was associated with higher odds of myasthenia gravis (MG; OR = 1.67), whereas higher glucose levels showed an inverse association with MG (OR = 0.50). Genetically predicted higher weight was also associated with higher glucose levels (β = 0.06), and the MR ...
Hai Lin   +12 more
wiley   +1 more source

Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the FDA Adverse Event Reporting System

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Neurological immune‐related adverse events (N‐irAEs) from immune checkpoint inhibitors (ICIs) are rare but potentially fatal. This study aimed to characterize their real‐world profile to support early detection and management.
Tao Chen   +5 more
wiley   +1 more source

Seronegative Granulomatous Myositis With Bulbar Weakness and Reversible Cardiomyopathy: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT A 64‐year‐old woman presented with seronegative idiopathic granulomatous myositis, featuring severe bulbar weakness, reversible cardiomyopathy (ejection fraction 20%–25%), hepatic injury, and acute kidney injury. Muscle biopsy confirmed granulomatous inflammation.
Balachandran R. Vaidyanathan   +2 more
wiley   +1 more source

Myasthenia Gravis [PDF]

open access: yesAutoimmune Diseases, 2011
Aarli, Johan A.   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy